New report highlights critical role of pharmaceutical distributors in Canada

Canada’s pharmaceutical distributors are delivering more than 90 per cent of the country’s prescription medications, but face mounting challenges that threaten their ability to keep pace with rising demand, according to a new report released Thursday by the Canadian Association for Pharmacy Distribution Management (CAPDM).

The report, Pharmaceutical Distribution: The Value and Challenges of Supplying Medications to Canada’s Healthcare System, is based on analysis by IQVIA Canada. It highlights the vital but largely invisible work distributors perform in ensuring timely, accurate medication delivery to pharmacies, hospitals, and clinics across the country, including remote and northern communities.

“Distributors are the driving force behind Canada’s medication supply,” said Angelique Berg, president and CEO of CAPDM. “From high-volume urban centres to remote northern communities, pharmaceutical distributors ensure medications arrive safely, securely and on time. It’s a level of reliability most people take for granted, but one that requires considerable expertise and a robust infrastructure.”

The report outlines key findings, including that distributors process an average of 240,000 orders per week, with more than 80 per cent delivered within 24 hours. Cold chain medications like biologics are increasing logistical complexity, and operating costs jumped 23 per cent between 2021 and 2022, while funding has stayed largely stagnant for over 15 years.

“Distributors have consistently demonstrated their ability to adapt and deliver—quietly, reliably, and without disruption,” said Berg. “It’s time to bring their role into the spotlight and ensure they are included in national conversations about healthcare planning, access, equity, and system resilience.”

Visit here for the full report.